Clinical Lab Leadership Update
Incyte welcomes a new Medical Director and Laboratory Manager.
COVID-19 Antibody Testing
Risk Associated Breast Lesions Core Needle Biopsy
By Hongxiu Ji, MD, PhD
A palpable or imaging-detected breast lesion is often first evaluated by core needle biopsy (CNB) under ultrasound, stereotactic or MRI guidance. The pathology can be divided into three categories: benign, malignant and risk-associated breast lesions.
The Milan System for Reporting Salivary Gland Cytopathology
By Liqun Yin, MD
Salivary gland cytology presents many diagnostic challenges. Salivary gland tumors are one of the most heterogeneous groups of neoplasms, and salivary gland tumors are one of the most difficult areas of evaluation in cytology. The FNA sensitivity is between 86-100% with specificity somewhere between 48-94%.
David C. Hoak, M.D. Retires after 25 Years of Service
Dr. Hoak has been with Incyte Diagnostics since 1993. Over the past 25 years, he has served as President of Incyte Diagnostics, Medical Director of the Spokane laboratory, and chaired numerous committees.
Incyte Diagnostics Welcomes New Pathologists
Incyte Diagnostics has recently welcomed several subspecialty-trained pathologists to our team of pathologists.
ICD-10: Coding Gynecological Specimens for Laboratory
By Tiris Mjelde
The practice of medicine has changed dramatically in the last 25 years or so. New conditions have been discovered and many new treatments and medical devices have been developed. The ICD-10 code set that became effective on October 1, 2015, tries to capture the current practice of medicine and provide flexibility as it changes in the future.
Incyte Diagnostics and Blue Mountain Pathology Announce Acquisition
Spokane, WA and Pendleton, OR—Incyte Diagnostics based in Spokane, Bellevue, Walla Walla and Yakima, WA and Blue Mountain Pathology based in Pendleton, OR have entered into a letter of intent to combine their two pathology practices. This transaction will create a regional pathology practice where physicians and hospitals can access 47 board certified pathologists with expertise in 27 disciplines/subspecialties.
Incyte Diagnostics Welcomes Ajit Alles, MBBS, PhD
Incyte Diagnostics is pleased to announce that Ajit Alles, MBBS, PhD, has joined our organization. Dr. Alles is board certified in pediatric pathology as well as anatomic and clinical pathology.
Multiple Options Available for Effective Cervical Cancer Prevention
By Hongxiu Ji, M.D., Ph.D.
Once the leading cause of cancer death in women, cancer of the uterine cervix has become a rare disease, thanks to the implementation of prevention programs. In fact, cervical cancer prevention represents the most successful story in cancer control so far.
